Department of Oncology, Ålesund Hospital, Ålesund, Norway.
Department of Medicine and Healthcare, Ålesund Hospital, Ålesund, Norway; Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway.
Phys Med. 2018 Jan;45:12-18. doi: 10.1016/j.ejmp.2017.11.019. Epub 2017 Dec 19.
The aim of our study was to evaluate and compare the robustness of treatment plans produced using the volumetric modulated arc-therapy (VMAT) and the standard three-dimensional conformal radiotherapy (3DCRT) techniques by estimating perturbed doses induced by localization offsets for deep inspiration breath-hold (DIBH) in locally advanced breast cancer radiation therapy.
Twenty patients with left breast carcinoma requiring radiation therapy were analysed in this planning study. Robust VMAT plans regarding minimum CTV doses and standard 3DCRT plans were produced, and perturbed doses were calculated in accordance with localization values from the weekly offline imaging protocol. Offsets from 5 weeks were summed to a perturbed overall treatment plan. Dose criteria for evaluation were coverage and homogeneity of the target, as well as doses to organs at risk.
VMAT plans resulted in significantly better target coverage compared to 3DCRT, as well as lowered doses to heart and left anterior descending artery, while the perturbed doses were less variable for VMAT than 3DCRT plans. Homogeneity was significantly improved in VMAT plans. The statistical analysis taking all organs into account found that VMAT plans were more robust than 3DCRT to localization offsets (p = .001). The overall mean setup-deviation for the DIBH-patients was less than 2 mm in all directions.
VMAT plans were more robust on average than conventional 3DCRT plans for DIBH when localization errors were taken into consideration. The combination of robust VMAT planning and DIBH generally improves the homogeneity and target doses.
我们的研究目的是评估和比较使用容积调强弧形治疗(VMAT)和标准三维适形放疗(3DCRT)技术产生的治疗计划的稳健性,方法是通过估计局部晚期乳腺癌放射治疗中深吸气屏气(DIBH)的定位偏移引起的受扰剂量。
本研究对 20 例左侧乳腺癌需要放射治疗的患者进行了分析。针对最小 CTV 剂量生成了稳健的 VMAT 计划和标准的 3DCRT 计划,并根据每周离线成像方案的定位值计算了受扰剂量。从第 5 周开始的偏移量被加总到受扰的整体治疗计划中。评估的剂量标准是靶区的覆盖和均匀性,以及危及器官的剂量。
与 3DCRT 相比,VMAT 计划显著提高了靶区的覆盖,同时降低了心脏和左前降支的剂量,而 VMAT 计划的受扰剂量比 3DCRT 计划更稳定。VMAT 计划的均匀性得到了显著改善。考虑所有器官的统计分析发现,VMAT 计划比 3DCRT 计划对定位偏移更稳健(p=0.001)。DIBH 患者的总体平均设置偏差在所有方向上均小于 2mm。
考虑到定位误差,VMAT 计划平均比传统的 3DCRT 计划更稳健。稳健的 VMAT 计划和 DIBH 的结合通常可以提高均匀性和靶区剂量。